ImmunityBio stock today: IBRX slips in premarket as U.S.-Saudi biotech summit nears
ImmunityBio shares fell 0.8% to $2.57 in premarket trading Tuesday after jumping 10.7% on Monday. Around 13,000 shares changed hands before 5 a.m. ET. Investors are watching for news from the U.S.-Saudi Biotech Alliance Summit in San Francisco on Jan. 14, held alongside the J.P. Morgan Healthcare Conference.